DK0537555T3 - Krystallinsk etoposid-4-phosphatdiethanolat - Google Patents

Krystallinsk etoposid-4-phosphatdiethanolat

Info

Publication number
DK0537555T3
DK0537555T3 DK92116749.0T DK92116749T DK0537555T3 DK 0537555 T3 DK0537555 T3 DK 0537555T3 DK 92116749 T DK92116749 T DK 92116749T DK 0537555 T3 DK0537555 T3 DK 0537555T3
Authority
DK
Denmark
Prior art keywords
crystalline etoposide
phosphate diethanolate
etoposide
phosphate
diethanolate
Prior art date
Application number
DK92116749.0T
Other languages
Danish (da)
English (en)
Inventor
Denis Favreau
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0537555T3 publication Critical patent/DK0537555T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK92116749.0T 1991-10-08 1992-09-30 Krystallinsk etoposid-4-phosphatdiethanolat DK0537555T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,056 US5648474A (en) 1991-10-08 1991-10-08 Crystalline etoposide 4'-phosphate diethanolate

Publications (1)

Publication Number Publication Date
DK0537555T3 true DK0537555T3 (da) 1998-01-26

Family

ID=25097069

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92116749.0T DK0537555T3 (da) 1991-10-08 1992-09-30 Krystallinsk etoposid-4-phosphatdiethanolat

Country Status (27)

Country Link
US (1) US5648474A (fi)
EP (1) EP0537555B1 (fi)
JP (1) JP3205816B2 (fi)
KR (1) KR100243981B1 (fi)
CN (1) CN1030610C (fi)
AT (1) ATE156832T1 (fi)
AU (1) AU650572B2 (fi)
CA (1) CA2079581C (fi)
CZ (1) CZ283735B6 (fi)
DE (1) DE69221573T2 (fi)
DK (1) DK0537555T3 (fi)
EG (1) EG20187A (fi)
ES (1) ES2109970T3 (fi)
FI (1) FI105034B (fi)
GR (1) GR3025176T3 (fi)
HU (2) HU213606B (fi)
IL (1) IL103262A (fi)
MX (1) MX9205777A (fi)
MY (1) MY108969A (fi)
NO (1) NO178342C (fi)
NZ (1) NZ244521A (fi)
PH (1) PH31666A (fi)
PL (1) PL168332B1 (fi)
RU (1) RU2042686C1 (fi)
SK (1) SK278935B6 (fi)
TW (1) TW239863B (fi)
ZA (1) ZA926903B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914222A (en) * 1983-08-29 1990-04-03 Merck & Co., Inc. Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
EP0369369B1 (en) * 1988-11-16 1994-01-26 Nippon Kayaku Kabushiki Kaisha Dihydrate crystals of etoposide-2-dimethylamino compound hydrochloride and a process for production thereof
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides

Also Published As

Publication number Publication date
MX9205777A (es) 1993-04-01
KR100243981B1 (ko) 2000-02-01
NZ244521A (en) 1994-02-25
CZ283735B6 (cs) 1998-06-17
CN1071432A (zh) 1993-04-28
NO923754D0 (no) 1992-09-28
CN1030610C (zh) 1996-01-03
ATE156832T1 (de) 1997-08-15
IL103262A0 (en) 1993-02-21
FI924359A0 (fi) 1992-09-29
DE69221573D1 (de) 1997-09-18
AU650572B2 (en) 1994-06-23
HUT62309A (en) 1993-04-28
MY108969A (en) 1996-11-30
ZA926903B (en) 1993-05-03
EP0537555B1 (en) 1997-08-13
SK298692A3 (en) 1998-04-08
IL103262A (en) 1997-06-10
FI105034B (fi) 2000-05-31
NO923754L (no) 1993-04-13
PH31666A (en) 1999-01-12
PL168332B1 (pl) 1996-02-29
HU213606B (en) 1997-08-28
GR3025176T3 (en) 1998-02-27
DE69221573T2 (de) 1998-02-26
NO178342B (no) 1995-11-27
PL296078A1 (en) 1993-04-19
US5648474A (en) 1997-07-15
RU2042686C1 (ru) 1995-08-27
CA2079581A1 (en) 1993-04-09
EG20187A (en) 1997-09-30
CA2079581C (en) 2002-11-12
NO178342C (no) 1996-03-06
EP0537555A1 (en) 1993-04-21
CZ298692A3 (en) 1993-04-14
HU9203119D0 (en) 1992-12-28
KR930007968A (ko) 1993-05-20
ES2109970T3 (es) 1998-02-01
JP3205816B2 (ja) 2001-09-04
TW239863B (fi) 1995-02-01
FI924359A (fi) 1993-04-09
AU2530192A (en) 1993-04-22
SK278935B6 (sk) 1998-04-08
JPH05194575A (ja) 1993-08-03
HU211672A9 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
GB2237945B (en) Process,supply,temperature compensating CMOS output buffer
ZA916058B (en) Novel 1,4-dihydropyridine derivatives
DE69016235D1 (de) Hochtemperaturbauteil.
FI900627A0 (fi) 2,3,23-trihydroxiurs-12-en och dess derivat, foerfarande foer deras framstaellning och deras anvaendning.
DK0499157T3 (da) Fremgangsmåde til fremstilling af 1,3-dioxoler
PT88254A (pt) Processo para a preparacao de derivados de eritromicina a modificada em c.12
ATE156832T1 (de) Kristallines etoposid-4'-phosphat diäthanolat
NO911034D0 (no) Temperingsanordning for tidsinnstilt granat-brannroer.
IT9020783V0 (it) Apparecchio frigorifero,specialmente armadio frigorifero a 2 temperature
FI852554L (fi) Antibakteriella 7-oxo-4-tia-1- azabicyklo(3,2,0)hept-2-en derivat.
ES2073495T3 (es) Benzotiazepinas.
NO905244D0 (no) Fremgangsmaate for fremstilling av des(64,65)-proinsulin.
DE69112999D1 (de) Kristallisationsverfahren.
NO880789D0 (no) Feltjustering for varmebildeapparater.
DE59106983D1 (de) Vorrichtung zur Kompensation thermischer Dehnungen.
FI910684A (fi) En multifunktionell process regulator innehaollande en modell.
CS78790A2 (en) 6-amino-2-(2,4-dinitrophenyltio) benzothiazole
BR9106531A (pt) Processo de preparacao de 1,1-dicloro-1-fluoretano
FI895442A0 (fi) Saekerhetsanordning foer dykare.
IT8741603A0 (it) Procedimento per fabbricare articoli bimetallici.
NO902468D0 (no) Anordning for paavisning av temperatursprang.
VN94A6 (en) Tomato seed n.214